Product
Alvocidib
3 clinical trials
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Phase 2, Open-label, Randomized, Two-stage Clinical Study of Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia Following Treatment With Venetoclax Combination TherapyStatus: Terminated, Estimated PCD: 2021-04-22
Clinical trial
A Phase 1, Open-label, Dose-escalation, Safety and Biomarker Prediction of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Status: Completed, Estimated PCD: 2020-03-20
Clinical trial
Phase 2, Randomized, Biomarker-driven Clinical Study in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥30%Status: Terminated, Estimated PCD: 2020-02-12